CIBC Bancorp USA’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
CIBC Bancorp USA's ELV Position: Q3 2026 in Review
CIBC Bancorp USA reduced its Elevance Health (ELV) stake by 9.4% in Q3 2026, selling an estimated $14.3M and leaving 345,355 shares worth $135M. The position accounts for 0.17% of the portfolio, ranked #132.
CIBC Bancorp USA first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. The position peaked at $147M in Q2 2026. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- CIBC Bancorp USA held 345,355 shares of Elevance Health worth $135M as of Q3 2026.
- CIBC Bancorp USA sold 35,833 Elevance Health shares in Q3 2026, an estimated $14.3M.
- Elevance Health made up 0.17% of CIBC Bancorp USA's portfolio in Q3 2026, its #132 holding.
- CIBC Bancorp USA first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
- CIBC Bancorp USA's Elevance Health position peaked at $147M in Q2 2026.
- 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.